Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Aspirin or Dose Titration on BG00012 Tolerability
NCT01568112Phase 3Completed
- Sponsor
- Biogen
- Start
- Apr 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dimethyl fumarate in multiple sclerosis (MS), sponsored by Biogen. Started Apr 2012; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01568112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01568112.